Amylyx Pharmaceuticals Inc (AMLX) support and resistance · $561.6M cap
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
This page maps Amylyx Pharmaceuticals Inc (AMLX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
AMLX currently screens at market cap $561.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AMLX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AMLX quote page for the session range and the stock page for the full model.
Not investment advice.